By 2021, there will be a reduction in the import of pharmaceutical products containing insulin at the Central American level by 44%, equivalent to $1,948 million, with Costa Rica being the main buyer with $10 million.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graphic"]
For the second quarter of 2021, the purchase of pharmaceutical products in the region was dominated by Costa Rica with $428 million, the largest supplier to the region was Germany with $167 million.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graphic"]
Agencia Farmaceutica S.A., Corporacion Impa Doel S.A., Hispomedica SRL and Cefa Central Farmaceutica are among the companies that won contracts last year to supply medicines and pharmaceutical products to public health institutions in the region.
An analysis by CentralAmericaData's Business Intelligence department provides interesting data on the companies that in 2020 were awarded contracts to supply pharmaceutical products and medical supplies to the different Ministries of Health and Social Security entities in Central American countries and the Dominican Republic.
The Costa Rican Social Security Fund tenders the supply under the modality of delivery on demand of 10 mg hyoscine butylbromide, in its presentation of coated tablets.
Costa Rican Government Purchase 2020ME-000070-5101:
"For this tender it is estimated that 380,000 units of the medicine tendered must be supplied.
The purchase will be made for a period of 12 months with the probability of extension for three additional years, for a total of four years, because it saves the institution to make purchases every year and maintains the best price for up to four years.
From January to March 2020, pharmaceutical product imports in Central America totaled $825 million, with Costa Rica and Guatemala being the markets where purchases increased the most.
Figures from CentralAmericaData's Commercial Intelligence Unit: [GRAFICA caption="Click to interact with graphic"]
The Fischel Nunciatura drugstore, located near La Sabana Park in San Jose, Costa Rica, is a sales point that is a 15-minute walk away and has a potential market of over 23,000 consumers, 11% of whom are interested in health care issues.
Using the Geomarketing solutions we have developed for our clients, CentralAmericaData's Trade Intelligence team analyzed the environment of some of the main locations of the drugstores in Central America. Below is an extract of the study's findings.
Since Farmacias Sucre acquired most of the shares of Farmacias Santa Lucía in Costa Rica, sales of the latter have increased by 70%, mainly because of investments made in inventory.
Reprico, Labymed, J.J. Cohen, Novartis and Nipro Medical Corporation are some of the firms supplying medicines to public health institutions in the region.
Figures from the information system, "Public Purchases in the Health Sector" developed by the Trade Intelligence area of CentralAmericaData, details the list of companies favored with contracts to provide pharmaceutical products and medical supplies in tenders published between July 2017 and June 2018, by the several Ministries of Health and Social Security of Central American countries.
The Costa Rican Social Security Fund is putting out to tender a supply of various types of medicines.
Costa Rica Government Purchase 2018ME-000115-5101:
"Beclomethasone dipropionate 100 ug / dose in extra fine aerosol solution for oral inhalation, pressurized bottle with 200 doses, does not contain CFC, amount required 1,100,000."
From January to November 2017, countries in the region imported $264 million worth of pharmaceutical products from Mexico, and 50% was acquired by companies in Panama.
Figures from the information system "Trade between Central America and Mexico", compiled by the Business Intelligence Unit at CentralAmericaData : [GRAFICA caption = "Click to interact with graph"]
Products, services, and medical, pharmaceutical and hospital technology equipment will be exhibited from October 19th to 20th at the Atlapa Convention Center.
The EXPO MEDICA PANAMÁ 2017 event will bring together companies from the pharmaceutical, medical, health and sports industries.
Participating companies will explore business opportunities and showcase beauty, sports, and gym products, among other things.
46% of the funds to be spent in 2017 will go towards purchasing cancer drugs, vaccines, antiretrovirals and antihypertensives.
In the purchase of vaccines alone, almost $17 million has been earmarked for the acquisition of 2.3 million doses against various diseases.
The budget of $207 million for procurement of drugs in 2017 was approved by the board of the Costa Rican Social Security Department (CCSS), and recorded an increase of $4 million compared to 2016.
In the 2017 budget approved for the Costa Rican Social Security Department an additional $270 million has been allocated for drugs, and $95 million for infrastructure.
From a statement issued by the Costa Rican Social Security Department (CCSS):
The Board of Directors of the Costa Rican Social Security Department (CCSS) approved on Thursday, the institution's budget for 2017 in the amount of ¢3.4 billion
The Costa Rican Department of Social Security is putting out to tender kits containing 100 chemical and biological reagents tests to detect HIV antigens and antibodies.
Costa Rica Government Purchase 2016LN-000018-05101:
"Kits each containing 100 chemical and biological reagents tests to detect antigens and antibodies to the human immunodeficiency virus.
The Costa Rican Social Security Department has approved the acquisition of 1.7 million bottles of the drug used to control diabetes.
Arguing that the prevalence of diabetes is increasing, authorities at the Social Security Department (CCSS) approved allocating $5.2 million for purchase of medicine to control it.
From a statement issued by the Social Security Department: